127 results
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
, operating results, and financial condition. Furthermore, as the majority of AutoMax’s customers rely on credit financing to purchase vehicles … the majority of its revenues and AutoMax’s management, marketing, sales and research and development costs are in NIS. AutoMax is therefore exposed
425
SPRC
SciSparc Ltd
2 May 24
Business combination disclosure
4:46pm
, rejected by a majority of votes the amendment to the Basic Law: the Judiciary (Reduction of the Reason for Reasonableness).
F-18
Automax Motors Ltd … will be appointed by the marketer and one by the subsidiary. The Founder’s Agreement also stipulates that certain decisions will require a 100% majority
6-K
EX-99.2
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
the majority of the board of directors of the combined company following the consummation of the Acquisition; and
SciSparc’s senior management
6-K
EX-99.1
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
Court, in its session as the High Court of Justice, rejected by a majority of votes the amendment to the Basic Law: the Judiciary (Reduction … decisions will require a 100% majority of the directors, including a change in the joint company’s incorporation documents, including a change
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
and restrictions.
Effective control:
The Company assesses whether it controls a company in which it holds less than the majority of the voting rights by, among … ., a majority owned subsidiary of the Company, as further described in the Company’s Report on Form 6-K, filed on May 19, 2020. The Suit claims
425
1i97 b5qph690n5r
12 Apr 24
Business combination disclosure
9:23am
6-K
EX-99.1
46jv 5g9fw493
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
u2wkc6h3dks0oktzzo
1 Apr 24
Registration of securities for employees
5:11pm
F-1
EX-10.7
a03yi6mg8zwyd
27 Feb 24
Registration statement (foreign)
4:15pm
F-1
a3o293j
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-10.1
p5fe7be98rxakki
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-4.1
snavsp0sy7 hs1
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-4.1
ldmd3zem5alf d1rbg
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
a8avi qyml6j885bf58s
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
9ms9nt
27 Nov 23
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
4:00pm
F-3/A
z7eko8ec32l cpv2xe
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
zw60nb gzqvnzd9a00
3 Nov 23
Shelf registration (foreign)
4:06pm